We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Forced to Repeat Studies in Light of Suspect Cetero Data
Sponsors Forced to Repeat Studies in Light of Suspect Cetero Data
May 8, 2012
Some generic-drug makers who used the discredited contract research organization (CRO) Cetero Research will need to reanalyze or repeat studies, while others will need to conduct an independent third-party data audit, the FDA told drugmakers.